✦ LIBER ✦

1032 POSTER Safety and efficacy of the combination chemotherapy consisting of S-1 and cisplatin (CDDP) on patients with advanced/recurrent head and neck cancer (HNC) (phase I/II study)

Book ID: 122536288
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 146 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(05)81327-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of S-1 combined with ca

Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy

✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o

8538 POSTER A Phase II Study of Inductio

8538 POSTER A Phase II Study of Induction Chemotherapy With Docetaxel, S-1, and Cisplatin in Patients With Locally Advanced Head & Neck Squamous Cell Cancer (HNSCC) – Preliminary Results

✍ Kyoung, K. Min; Song, S.Y.; Kang, M.K.; Lee, K.H.; Jang, H.W.; Song, H.S.; Kwon, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

583 Induction Chemotherapy with Docetaxe

583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

✍ Perri, F.; Muto, P.; Schiavone, C.; Ionna, F.; Aversa, C.; Maiolino, P.; Cavalca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

8546 POSTER A Phase II Study of Docetaxe

8546 POSTER A Phase II Study of Docetaxel, Cisplatin, and Oral S-1 Induction Chemotherapy Followed by Chemoradiotherapy in Advanced Squamous Cell Cancer of the Head and Neck – Preliminary Results: a Trial of the Korean South West Oncology Group

✍ Bae, W.; Kim, K.; Joo, Y.; Chung, I.; Cho, S.; Lee, K.; Song, E.; Yun, H.; Cho, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase I study on the safety, pharmacokin

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma

✍ Ikeda, Masafumi; Shiina, Shuichiro; Nakachi, Kohei; Mitsunaga, Shuichi; Shimizu, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 403 KB

8517 Phase I results from an open-label,

8517 Phase I results from an open-label, randomized, controlled, phase I/II study (ADVANTAGE) to evaluate the combination of different cilengitide regimens with cisplatin, 5-FU, and cetuximab in patients with recurrent/metastatic squamous cell cancer of the head and neck (SCCHN)

✍ Brümmendorf, T.; Guigay, J.; Mesía, R.; Trigo, J.; Keilholz, U.; Dittrich, C.; K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB